FindTrial
Sign In

IncobotulinumtoxinA (Xeomin) (20 Units)

DRUG4 trials

Sponsors

Merz Pharmaceuticals GmbH

Conditions

Glabellar Frown LinesGlabellar LinesModerate to Severe Glabellar Frown Lines

Phase 3

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
CompletedNCT00430963
Merz Pharmaceuticals GmbHGlabellar Frown Lines
Start: 2006-10-31End: 2007-11-30Updated: 2011-10-26
Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines
CompletedNCT00512135
Merz Pharmaceuticals GmbHGlabellar Lines
Start: 2007-06-18End: 2009-12-28Updated: 2021-04-02
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2
CompletedNCT00770029
Merz Pharmaceuticals GmbHModerate to Severe Glabellar Frown Lines
Start: 2008-10-31End: 2009-06-30Updated: 2013-02-27
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
CompletedNCT00770211
Merz Pharmaceuticals GmbHModerate to Severe Glabellar Frown Lines
Start: 2008-10-31End: 2009-06-30Updated: 2011-10-07